Patients with the PN subtype GBM are younger, and this subtype is characterized by platelet‐derived growth factor receptor, alpha polypeptide (PDGFRA) amplification and isocitrate dehydrogenase 1(IDH1) mutation. The gene discussed is IDH1; the disease is glioblastoma.